Cultured pluripotent stem cells (PSCs) acquire genetic changes — gains or losses of entire chromosomal regions, or point mutations, including in cancer-associated genes such as TP53. Recent work provides insights into the mechanisms of mutation and selection, which have implications for the use of human PSCs in regenerative medicine.
- Jason Halliwell
- Ivana Barbaric
- Peter W. Andrews